Pro MedicusPMDIY 77 EBIT per Share is $0.22 as of Dec. 2025. GuruFocus rates PMDIY with a GF Score™ of 77/100 and a GF Value™ of $40.45 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 529 Healthcare Providers & Services companies, Pro Medicus ranks better than 78.45% on this metric.
Pro Medicus's EBIT per Share for the
six
months ended in Dec. 2025 was $0.12.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.22.
During the past 12 months, the average EBIT per Share Growth Rate of Pro Medicus was 33.90% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 36.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 38.90% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 40.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Pro Medicus's EBIT per Share or its related term are showing as below:
PMDIY'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -53.4 Med: 28.4 Max: 217.5
Current: 36.2
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Pro Medicus was 217.50% per year. The lowest was -53.40% per year. And the median was 28.40% per year.
PMDIY's 3-Year EBIT Growth Rate is ranked better than 78.45% of 529
companies
in the Healthcare Providers & Services industry
Industry Median: 11.8
vs PMDIY: 36.20
Pro Medicus's EBIT for the
six
months ended in Dec. 2025 was $60.2 Mil.
Pro Medicus (OTCPK:PMDIY) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Pro Medicus EBIT per Share Related Terms
Pro Medicus EBIT per Share Historical Data
* Premium members only.
The historical data trend for Pro Medicus's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.22
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pro Medicus (PMDIY) has a EBIT per Share of $0.22 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Pro Medicus and its competitors. According to the industry distribution chart, Pro Medicus ranks #114 out of 529 companies in the Healthcare Providers & Services industry, placing it in the top 21.6%.
Is Pro Medicus' EBIT per Share too high?
Pro Medicus' current EBIT per Share is $0.22. The Healthcare Providers & Services industry median EBIT per Share is 11.80. Pro Medicus' value of $0.22 is 98.1% below this industry median. Based on the distribution chart, Pro Medicus ranks #114 out of 529 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pro Medicus has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pro Medicus' EBIT per Share compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Pro Medicus ranks #114 out of 529 companies for EBIT per Share. This places Pro Medicus in the top 22% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 11.80. Pro Medicus' value of $0.22 is 98.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.80, based on 529 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pro Medicus's current EBIT per Share of $0.22 is 98.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Pro Medicus and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pro Medicus's current EBIT per Share is $0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro Medicus stock overvalued right now?
Based on GuruFocus' analysis, Pro Medicus (PMDIY) is currently considered Modestly Undervalued. The stock's GF Value™ is $40.45, compared to a current price of $29.00 — trading 28.3% below its estimated fair value. The current EBIT per Share is $0.22 and 98.1% below the Healthcare Providers & Services industry median of 11.80. Pro Medicus' overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Pro Medicus (PMDIY), the current EBIT per Share is $0.22 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pro Medicus (PMDIY) Overvalued in 2026?
Based on GuruFocus' analysis, Pro Medicus stock appears to be undervalued.
The current stock price of $29.00 is trading 28.3% below its estimated GF Value™ of $40.45.
GuruFocus considers Pro Medicus to be Modestly Undervalued.
Key valuation signals for PMDIY:
EBIT per Share: $0.22
GF Value™: $40.45 vs. price of $29.00 (28.3% below fair value)
Industry Position: 98.1% below the Healthcare Providers & Services median (#114 of 529)
No single metric tells the full story. See the PMDIY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
77GF Score
Get the complete analysis for PMDIY
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMDIY has been successfully added to your 
